Philipp Widmann Joins as a Managing Director; Henning Stoltze Joins as a Director FRANKFURT, Germany–(BUSINESS WIRE)–Houlihan Lokey, Inc. (NYSE:HLI), the globalPhilipp Widmann Joins as a Managing Director; Henning Stoltze Joins as a Director FRANKFURT, Germany–(BUSINESS WIRE)–Houlihan Lokey, Inc. (NYSE:HLI), the global

Houlihan Lokey Expands Specialty Distribution Capabilities With Senior European Hires

4 min read

Philipp Widmann Joins as a Managing Director; Henning Stoltze Joins as a Director

FRANKFURT, Germany–(BUSINESS WIRE)–Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, announced two senior appointments in its global Industrials Group, as the firm expands its coverage of the specialty distribution sector in Europe.

Philipp Widmann has joined the firm from Baird as a Managing Director to lead the new team. Based in Frankfurt, he will work alongside senior colleagues in the firm’s market-leading distribution team in the U.S., as well as colleagues across the broader Industrials Group, to deliver bespoke, cross-border solutions to clients in the region.

Over more than a decade at Baird, Mr. Widmann advised clients on M&A and capital markets transactions across the business-to-business distribution sector. He brings extensive corporate finance expertise and a deep network of client and investor relationships across Europe’s distribution markets.

Henning Stoltze has joined the firm as a Director, also from Baird, where he worked closely with Mr. Widmann and spent the majority of his career focusing on the specialty distribution sector. He will also be based in the Frankfurt office.

The hires reflect the ongoing momentum of Houlihan Lokey’s Industrials Group in Europe, following the recent addition of Géraud Estrangin in Paris to focus on aerospace and defence, and further strengthen the team’s ability to deliver deep subsector expertise and innovative advisory solutions.

Bill Peluchiwski, Global Head of Industrials, said: “Philipp and Henning’s arrival represents yet another important milestone in the expansion of our global Industrials Group. Their appointment is indicative of our belief in the continued growth of the European specialty distribution market and exemplifies our focus on delivering outstanding, client-focused outcomes across the global markets where we operate.”

Reed Anderson, Co-Head of Specialty Distribution, commented: “We are excited to be expanding our market-leading North American Specialty Distribution practice by building out our European expertise, establishing a global platform that delivers enhanced advisory expertise and access across both continents. We look forward to partnering with Philipp and Henning to unlock more opportunities for our clients in both Europe and North America.”

Frank Merkel, Co-Head of Industrials, Europe, said: “We’re delighted to welcome Philipp and Henning to the Industrials Group. Hiring seasoned advisors of their profile materially enhances our expertise in specialty distribution, at a time of sustained momentum in Europe. Their deep sector knowledge, broad transaction experience, and established client relationships will accelerate the momentum of our European industrials platform, further reinforce our market leadership, and ensure we continue delivering innovative, high-impact solutions across diverse markets and subsectors.”

“I am delighted to be joining Houlihan Lokey as the firm expands its specialty distribution capabilities in Europe,” said Mr. Widmann. “Its unmatched depth of sector expertise, global reach, and collaborative culture provide a unique platform to deliver best-in-class solutions for clients. I look forward to contributing to the team’s ongoing momentum, leveraging our combined experience and relationships to support clients in achieving their strategic objectives and driving sustained growth across the region.”

Houlihan Lokey’s Industrials Group has earned a reputation for superior service and outstanding results in M&A advisory, capital-raising, restructuring, and financial and valuation advisory services. Our transaction quality and client work benefit from our company culture, where financial professionals are highly engaged in the execution of client projects, and from our experience as leaders in the market for more than a decade, which has given our professionals valuable exposure to a variety of situations and challenges. In 2025, Houlihan Lokey’s Industrials Group was ranked as the No. 1 M&A advisor for global industrials transactions under $5 billion, advising on a total of 71 deals.*

*2025 M&A Advisory Rankings—Global Industrials Transactions Under $5 Billion. LSEG. Excludes accounting firms and brokers.

About Houlihan Lokey

Houlihan Lokey, Inc. (NYSE:HLI) is a leading global investment bank recognized for delivering independent strategic and financial advice to corporations, financial sponsors, and governments. With uniquely deep industry expertise, broad international reach, and a partnership approach rooted in trust, the firm provides innovative, integrated solutions across mergers and acquisitions, capital solutions, financial restructuring, and financial and valuation advisory. Our unmatched transaction volumes provide differentiated, data-driven perspectives that help our clients achieve their most critical goals. To learn more about Houlihan Lokey, please visit HL.com.

Contacts

Investor Relations
+1 212.331.8225
IR@HL.com

Media Relations
+44 20 7747 1480
PR@HL.com

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29